Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.4000 (-0.78%) ($6.3500 - $6.5000) on Fri. Nov. 18, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.09% (three month average) | RSI | 71 | Latest Price | $6.4000(-0.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.8% a day on average for past five trading days. | Weekly Trend | CGEN advances 6.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IPO(5%) EWG(4%) TBT(4%) URA(4%) XRT(3%) | Factors Impacting CGEN price | CGEN will decline at least -1.045% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) TAN(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.045% (StdDev 2.09%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $6.59(-2.88%) | 10 Day Moving Average | $6.46(-0.93%) | 20 Day Moving Average | $6.14(4.23%) | To recent high | -13.6% | To recent low | 14.3% | Market Cap | $529m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |